Samsung Bioepis has announced the European launch of Obodence and Xbryk, two new denosumab biosimilars approved for the treatment of bone disease. Obodence, referencing Amgen’s Prolia, has been approved for the treatment of osteoporosis in postmenopausal women and in men at increased risk of...
Teva has announced positive results from the phase 4 PEARL study of AJOVY (fremanezumab), its treatment for chronic (CM) and episodic migraine (EM). AJOVY is an anti-calcitonin gene-related peptide (CGRP) monoclonal antibody administered as a subcutaneous injection. The PEARL study of AJOVY took...
Five Nights at Freddy’s 2 may be reviewing even worse than the panned original, but it’s clearly a hit with fans since its audience score is actually a little higher.
Continue reading →
A certain subset of the gaming population generally prefers turn-based battle systems over action. We’re a smaller group overall, but with the success of Baldur’s Gate 3 and this year’s Clair Obscur: Expedition 33, we’ve gotten louder again. Perhaps a bit annoyingly so;...
Where Winds Meet’s developers are clearly aware of some of the game’s exploits, as it appears to have recently patched one that let you avoid bounties by going offline.
Continue reading →
The deal for the party punch maker, which is popular among young drinkers for its high alcohol content, gives the beer giant a path to complete ownership after five years.
Continue reading →
The 2000s cultural icon is teaming with Danone's International Delight on three new creamers, while Guinness partners with luxury bakery Last Crumb on a $120 holiday cookie collection.
Continue reading →